Navigation Links
Neuisys Announces FDA Clearance of UroCARE
Date:4/27/2009

Unique Software Application Suite for the Assessment of the Urinary System

CHICAGO, April 27 /PRNewswire/ -- Neuisys, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today at the annual meeting of the American Urological Association that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of UroCARE(TM), a unique software application package for the assessment of urinary anatomy using multi-slice computed tomography (CT) data.

UroCARE is an exclusive software package developed by Neusoft Medical Systems for the NeuViz Dual and NeuViz 16 CT systems. UroCARE is also compatible with DICOM compliant CT image sets, including those from other CT manufacturers.

"The team at Neusoft is very proud to be at the forefront of clinical applications development for high-tech medical imaging," said Dr. Yan Kang, Vice President and General Manager of Medical IT at Neusoft. "The FDA clearance of UroCARE is an exciting milestone in Neusoft's development of computer assisted reading and evaluation (CARE) packages, and we must share the credit with our clinical partners who have helped our software engineers understand their specific needs from an anatomic and disease process point of view."

UroCARE uses proprietary image processing algorithms to analyze multi-phase CT images of the urinary tract. Its advanced clinical functionality provides a KUB (kidney, ureter, and bladder) view; automatic segmentation of kidneys, ureters, and bladder; and detection of urinary calculi with density and volume measurements. KUB radiography has long been a key part of the daily routine for urology practices. UroCARE's KUB-view can eliminate the need for a dedicated radiography room or the need for patient to go to another facility for a KUB.

"UroCARE was specifically designed for the urologic surgeon to facilitate decision making for ureteroscopy or lithotripsy," said Dr. Edward Janosko of Atlantic Urology in Wilmington, North Carolina and former Chief of Urology at Pitt Memorial Hospital/East Carolina University School of Medicine. "UroCARE enables the display of the entire collecting system as a 3-D pyelogram, which urologists are accustomed to reviewing for the detection of filling defects and to separate phleboliths from stones. UroCARE can also assist with the selection of an optimal percutaneous tract for nephrostolithomy. All of these capabilities are completed with a few clicks of the mouse. I know of no other system that can do this."

About Neuisys

Neuisys Imaging Systems Solutions, headquartered in Greensboro, North Carolina, is a leader in providing state-of-the-art CT and MR imaging systems to physician practices, community hospitals, and imaging centers. Neuisys is the North American distributor for Neusoft(R) Medical Systems and markets an array of products including the NeuViz Dual and NeuViz 16 multi-slice CT systems, the SuperStar HD open MRI system, multi-modality advanced visualization workstations, image management solutions, digital x-ray, and ultrasound products. For more information, please visit www.neuisys.com or call 877.299.9052.


'/>"/>
SOURCE Neuisys Imaging Systems Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Neuisys Announces FDA Clearance of NeuViz 16 Multi-Slice CT System
2. Inverness Medical Innovations Announces First Quarter 2009 Results
3. MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists
4. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
5. Attorney General Eric Holder Honors Florida Doctor and Announces $4.7 Million in Recovery Act Funds for State
6. Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing
7. MMR Announces Webinar to Demonstrate MyMedicalRecords PHR Product Line
8. Roche Announces New Co-pay Program in Pennsylvania that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
9. Roche Announces New Co-pay Program in Florida that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
10. Dialysis Corporation of America Announces First Quarter 2009 Earnings Release Date
11. Wounded Warrior Project (WWP) Announces Support for Soldier Ride from Boston Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... Cary, NC (PRWEB) , ... December 06, 2016 ... ... cancer research charity, is thrilled to formally announce its Not a Moment to ... Moment to Lose will rally supporters dedicated to declaring victory over cancer. The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble ... Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... NEW YORK , Dec. 5, 2016 /PRNewswire/ ... of penicillin in 1948, antibiotics have emerged as ... treating several infectious conditions. In addition, antibiotics are ... have undergone surgery, or immunocompromised patients (cancer patients ... both in healthcare and food production, has rapidly ...
(Date:12/5/2016)... 29, 2016 Several leading Alzheimer,s disease experts ... Inc. at 11 a.m. EST on December 6 ... Clinical Trials for Alzheimer,s Disease (CTAD). The program will ... disease and therapeutic targets that address deficient glucose metabolism ... recent failure of another therapy targeting the amyloid hypothesis, ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ... offering. ... The western blotting market is expected ... in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology: